HLA-DPA1/HLA-DPB1
Nomenclature
C57BL/6JSmo-H2-Aatm1(HLA-DPA1*02:02)H2-Ab1tm1(HLA-DPB1*03:01)Smoc
Cat. NO.
NM-HU-234679
Strain State
Repository Live
Gene Summary
Gene Symbol
H2-Aa
Model Description
Validation Data

Fig.1 Detection of HLA-DPA1/HLA-DPB1 expression in large intestine and spleen by RT-PCR.
Wild type: one band at 278 bp with primers F4/R4(mH2-Aa) and one band at 123 bp with primers F/R(mGapdh);
Heterozygous: one band at 278 bp with primers F4/R4(mH2-Aa) and one band at 107 bp with primers F1/R1(hHLA-DPA1) and one band at 123 bp with primers F/R(mGapdh).
Abbr. M, DNA marker; HE, heterozygous; WT, wild type.

Fig.2 Detection of HLA-DPA1/HLA-DPB1 expression in large intestine and spleen by RT-PCR.
Wild type: one band at 299 bp with primers F3/R3(mH2-Ab1) and one band at 123 bp with primers F/R(mGapdh);
Heterozygous: one band at 299 bp with primers F3/R3(mH2-Ab1), one band at 113 bp with primers F2/R2(hHLA-DPB1) and one band at 123 bp with primers F/R(mGapdh).
Abbr. M, DNA marker; HE, heterozygous; WT, wild type.

Fig.3 Detection of MHC-Ⅱ expression on B cells and DCs in Peripheral blood in 13-week-old WT C57BL/6 and HE HLA-DPA1/HLA-DPB1 mice.

Fig.4 Detection of MHC-Ⅱ expression on B cells and DCs in Spleen in 13-week-old WT C57BL/6 and HE HLA-DPA1/HLA-DPB1 mice.

Fig.5 Detection of MHC-II expression on B cells in blood of WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice by FACS. Leukocytes were collected from wild-type C57BL/6 mice (male, 6 weeks old) and homozygous HLA-DPA1/HLA-DPB1 humanized mice (male, 6 weeks old), and analyzed by flow cytometry with anti-mMHC-II and anti-hMHC-II. hMHC-II was exclusively detectable in HLA-DPA1/HLA-DPB1 humanized mice but not in wild-type mice. hMHC-II was exclusively detectable on B cells in HLA-DPA1/HLA-DPB1 humanized mice, whereas mMHC-II was exclusively detectable on B cells in wild-type C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.

Fig.6 Detection of MHC-II expression on B cells and DCs in spleen of WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice by FACS. Leukocytes were collected from wild-type C57BL/6 mice (male, 6 weeks old) and homozygous HLA-DPA1/HLA-DPB1 humanized mice (male, 6 weeks old), and analyzed by flow cytometry with anti-mMHC-II and anti-hMHC-II. hMHC-II was exclusively detectable in HLA-DPA1/HLA-DPB1 humanized mice but not in wild-type mice. hMHC-II was exclusively detectable on B cells and DCs in HLA-DPA1/HLA-DPB1 humanized mice, whereas mMHC-II was exclusively detectable on B cells and DCs in wild-type C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.

Fig 7. Frequency of leukocyte subpopulations in the blood by flow cytometry
Blood was collected from WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice (7-week-old, n=3). Flow cytometry analysis of frequencies of (A) female and (B) male subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 8. Frequency of myeloid subpopulations in the blood by flow cytometry
Blood was collected from WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice (7-week-old, n=3). Flow cytometry analysis of frequencies of (A) female and (B) male subpopulations in the blood. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 9. Frequency of leukocyte subpopulations in the spleen by flow cytometry
Spleen was collected from WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice (7-week-old, n=3). Flow cytometry analysis of frequencies of (A) female and (B) male subpopulations in the spleen. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.

Fig 10. Frequency of myeloid subpopulations in the spleen by flow cytometry
Spleen was collected from WT C57BL/6 mice and HO HLA-DPA1/HLA-DPB1 mice (7-week-old, n=3). Flow cytometry analysis of frequencies of (A) female and (B) male subpopulations in the spleen. Bar indicated expressed as mean ± SEM.
Abbr. HO, homozygous; WT, wild type.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn moreMilestones
Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
Learn more